CD274 and renal carcinoma: In the present study, we show that that the combination treatment with RAPA and Honokiol effectively restricts the growth and cell cycle progression of renal cancer cells by inhibiting the c-Met-HO-1 axis; it also down-regulates the expression of PD-L1, which plays a major role in the immune escape of renal cancer cells.